Infliximab population pharmacokinetic modelling in patients with Inflammatory Bowel Disease (IBD): Patient factors influencing infliximab pharmacokinetics

被引：0
|
作者：
Guardiola, J. [1 ]
Rodriguez-Alonso, L. [1 ]
Santacana, E. [2 ]
Padulles, N. [2 ]
Colom, H. [3 ]
Padulles, A. [2 ]
Arajol, C. [1 ]
Ruiz-Cerulla, A. [1 ]
Cobo, S. [2 ]
Bas, J. [4 ]
Climent, J. [4 ]
Morandeira, F. [4 ]
Rodriguez-Moranta, F. [1 ]
机构：
[1] Hosp Univ Bellvitge, Gastroenterol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Bellvitge, Pharm, Lhospitalet De Llobregat, Spain
[3] Univ Barcelona, Sch Pharm, Pharmacokinet, Barcelona, Spain
[4] Hosp Univ Bellvitge, Immunol, Lhospitalet De Llobregat, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P453
引用
收藏
页码：S306 / S307
页数：2
相关论文
共 50 条
  • [11] VALIDATION OF AN INFLIXIMAB POPULATION PHARMACOKINETIC MODEL FOR MAINTENANCE DOSING IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Singer, Jason
    Tong, Dominic
    Cumming, Celine
    Hughes, Jasmine
    Holmes, Maya
    Sferra, Thomas
    Moses, Jonathan
    Finkler, Michael
    GASTROENTEROLOGY, 2024, 166 (03) : S103 - S104
  • [12] VALIDATION OF AN INFLIXIMAB POPULATION PHARMACOKINETIC MODEL FOR MAINTENANCE DOSING IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Singer, Jason
    Tong, Dominic
    Cumming, Celine
    Hughes, Jasmine
    Holmes, Maya
    Sferra, Thomas
    Moses, Jonathan
    Finkler, Michael
    INFLAMMATORY BOWEL DISEASES, 2024, 30
  • [13] Infliximab in paediatric inflammatory bowel disease: External evaluation of population pharmacokinetic models
    Heikal, Omnia Salah
    van Rheenen, Patrick F.
    Touw, Daan J.
    Kosterink, Jos G. W.
    Maurer, Marina
    Koomen, Jeroen V.
    Chelle, Pierre
    Mian, Paola
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (09) : 2200 - 2214
  • [14] Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice
    Buurman, D. J.
    Maurer, J. M.
    Keizer, R. J.
    Kosterink, J. G. W.
    Dijkstra, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (05) : 529 - 539
  • [15] External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease
    Schraepel, Christina
    Kovar, Lukas
    Selzer, Dominik
    Hofmann, Ute
    Tran, Florian
    Reinisch, Walter
    Schwab, Matthias
    Lehr, Thorsten
    PHARMACEUTICS, 2021, 13 (09)
  • [16] REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Bauman, Laura E.
    Xiong, Ye
    Mizuno, Tomoyuki
    Fukuda, Tsuyoshi
    Dong, Min
    Rosen, Michael J.
    Vinks, Alexander A.
    GASTROENTEROLOGY, 2018, 154 (01) : S83 - S83
  • [17] Clinical and biochemical correlates of infliximab pharmacokinetics in adult patients with Inflammatory Bowel Disease
    Pool, I. A.
    Volkerink, I
    Stavast, M.
    Kosterink, J. G. W.
    Dijkstra, G.
    Mian, P.
    Bourgonje, A. R.
    JOURNAL OF CROHNS & COLITIS, 2025, 19
  • [18] Pharmacokinetics, pharmacodynamics, and immunogenicity of biosimilar infliximab in pediatric patients with inflammatory bowel disease
    Dipasquale, V.
    Alibrandi, A.
    Pellegrino, S.
    Ramistella, V.
    Romano, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1618 - I1618
  • [19] The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease
    Seow, C. H.
    Leung, Y.
    Vande Casteele, N.
    Afshar, E. Ehteshami
    Tanyingoh, D.
    Bindra, G.
    Stewart, M. J.
    Beck, P. L.
    Kaplan, G. G.
    Ghosh, S.
    Panaccione, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (10) : 1329 - 1338
  • [20] Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
    Hemperly, Amy
    Vande Casteele, Niels
    CLINICAL PHARMACOKINETICS, 2018, 57 (08) : 929 - 942
12345